vimarsana.com

Page 146 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Advarra Acquires Bio-Optronics, Maker of Clinical Conductor TrialSuite™

Share this article Share this article COLUMBIA, Md., March 9, 2021 /PRNewswire/  Advarra, the market leader in regulatory review solutions, research quality and compliance consulting services and clinical site-centric technologies, today announced that it has acquired Bio-Optronics, maker of CCTrialSuite - which includes Clinical Conductor, the leading clinical trial management system (CTMS) for health systems and research sites, and an integrated suite of eClinical solutions.  The acquisition, in combination with Advarra s existing suite of products and services, establishes Advarra as the site technology market leader with extensive reach, customer loyalty and the highest standards of customer support to the 50,000 investigators whose sites run on Advarra software. 

VillageMD to Expand into Rhode Island, Opening 12 New Village Medical Practices

VillageMD to Expand into Rhode Island, Opening 12 New Village Medical Practices Experienced Local Physicians to Join VillageMD and Nation s Fast-Growing Primary Care Practice, Village Medical News provided by Share this article Share this article CHICAGO, March 9, 2021 /PRNewswire/ VillageMD announced today it expanded into Rhode Island and opened 12 new Village Medical practices on March 1. The Village Medical clinics are located in Providence, Kent, Newport and Washington counties with nearly 70 primary care providers including experienced physicians, nurse practitioners and physician assistants. The 12 clinics are the first Village Medical locations in Rhode Island and the 65 th for the brand, including practices in Austin, Atlanta, Chicago, Houston, Murray, Ky., Northfield, N.J., Westland, Mich., and Phoenix.  Village Medical offers comprehensive primary care across a broad range of physician services, along with virtual care and telehealth.

Study Maps Key Proteins Linked to Epilepsy, Revealing New Drug Targets

Study Maps Key Proteins Linked to Epilepsy, Revealing New Drug Targets News provided by Share this article Share this article NEW YORK, March 9, 2021 /PRNewswire/ An analysis of adult human brain tissue reveals over 900 proteins tied to epilepsy. The brain disorder, estimated to afflict more than 3 million Americans, is mostly known for symptoms of hallucinations, dreamlike states, and uncontrolled, often disabling bodily seizures. Led by researchers at NYU Grossman School of Medicine, the study examined molecular differences among the brains of 14 epilepsy patients and another group of 14 adults of similar age and gender who did not have the disease. Study results showed that altered levels of brain proteins predominated in the hippocampus, a structure located deep inside the skull and responsible for memory and learning. However, some 134 proteins were significantly changed in both the hippocampus and frontal cortex, the front third of the brain, which is also responsible f

Orca Therapeutics to start highest dose in treatment-naïve prostate cancer

ORCA Therapeutics B.V. , a clinical-stage biopharmaceutical company developing oncolytic viruses to treat solid tumors, is pleased to announce that, upon review of all safety data from the fully enrolled, low- and mid-dose patient cohorts of the ongoing Phase 1/2a clinical study of ORCA-010 in treatment-naïve patients with localized prostate cancer, the independent Data and Safety Monitoring Board (DSMB) unanimously recommended the continuation of the study without modification. From this recommendation, ORCA Therapeutics will initiate administration of the highest scheduled dose level of ORCA-010 in the single dose part of the study. Following this recommendation, ORCA Therapeutics B.V. has commenced enrollment in the highest-dose arm of the dose-escalation phase of this study, with the first patient scheduled for administration in March 2021. Upon conclusion of enrollment in the highest study arm, DSMB will conduct an additional review on ORCA-010 prior to starting the repeat

Nordic Consulting hires Lauren Verdery as Senior Vice President of Brand, Marketing and Communications

Nordic Consulting hires Lauren Verdery as Senior Vice President of Brand, Marketing and Communications News provided by Share this article Share this article MADISON, Wis., March 9, 2021 /PRNewswire/  Nordic Consulting, a global healthcare consulting firm, is proud to announce the hiring of Lauren Verdery as senior vice president of Brand, Marketing and Communications. Verdery brings over two decades of experience that spans the globe. As Nordic continues to expand its international footprint, Verdery will oversee the company s brand strategy to effectively reach healthcare leaders in the U.S. and abroad. Nordic Consulting hires Lauren Verdery as senior vice president of Brand, Marketing and Communications.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.